Swipe om te navigeren naar een ander artikel
To examine the responsiveness of Functional Assessment of Cancer Therapy-Prostate (FACT-P) and Short Form-12 Health Survey version 2 (SF-12 v2) in prostate cancer patients because there is a lack of evidence to support their responsiveness in this patient population.
One hundred sixty-eight subjects with prostate cancer were surveyed at baseline and at 6 months using the SF-12 v2 and FACT-P version 4. Internal responsiveness was assessed using paired t test and generalized estimating equation. External responsiveness was evaluated using receiver operating characteristic curve analysis.
The internal responsiveness of the FACT-P and SF-12 v2 to detect positive change was satisfactory. The FACT-P and SF-12 v2 could not detect negative change. The FACT-P and the SF-12 v2 performed the best in distinguishing between improved general health and worsened general health. The FACT-P performed better in distinguishing between unchanged general health and worsened general health. The SF-12 v2 performed better in distinguishing between unchanged general health and improved general health.
Positive change detected by these measures should be interpreted with caution as they might be too responsive to detect “noise,” which is not clinically significant. The ability of the FACT-P and the SF-12 v2 to detect negative change was disappointing. The internal and external responsiveness of the social well-being of the FACT-P cannot be supported, suggesting that it is not suitable to longitudinally monitor the social component of HRQOL in prostate cancer patients. The study suggested that generic and disease-specific measures should be used together to complement each other.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Siegel, R., et al. (2014). Cancer statistics, 2014. CA: A Cancer Journal for Clinicians, 64(1), 9–29.
Smith, D. P., et al. (2009). Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. BMJ, 339, b4817.
Choi, E. P., et al. (2016). Health-related quality of life of Chinese patients with prostate cancer in comparison to general population and other cancer populations. Support Care Cancer. doi: 10.1007/s00520-015-2980-6.
Hamoen, E. H., et al. (2015). Measuring health-related quality of life in men with prostate cancer: A systematic review of the most used questionnaires and their validity. Urology and Oncology, 33(2), 69 e19–28.
Rnic, K., et al. (2013). Measuring symptoms in localized prostate cancer: a systematic review of assessment instruments. Prostate Cancer and Prostatic Diseases, 16(2), 111–122. PubMed
Kamper, S. J., Maher, C. G., & Mackay, G. (2009). Global rating of change scales: A review of strengths and weaknesses and considerations for design. Journal of Manual & Manipulative Therapy, 17(3), 163–170. CrossRef
Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale: Lawrence Erlbaum Associates.
Efron, B. (1987). Better bootstrap confidence intervals. Journal of the American Statistical Association, 82(397), 171–185. CrossRef
Rubin, D. B. (2004). Multiple imputation for nonresponse in surveys (Vol. 81). New Jersey: Wiley.
- The internal and external responsiveness of Functional Assessment of Cancer Therapy-Prostate (FACT-P) and Short Form-12 Health Survey version 2 (SF-12 v2) in patients with prostate cancer
Edmond P. H. Choi
Carlos K. H. Wong
Eric Y. F. Wan
James H. L. Tsu
W. Y. Chin
M. K. Yiu
- Springer International Publishing